Therapeutic agent for diarrhea-type irritable bowel syndrome

Details for Australian Patent Application No. 2005209112 (hide)

Owner Astellas Pharma Inc.

Inventors Niwa, Akira; Atsuta, Yutaka; Nishida, Akito

Agent Davies Collison Cave

Pub. Number AU-B-2005209112

PCT Pub. Number WO2005/072730

Priority PCT/ JP2004/006657 12.05.04 JP; PCT/ JP2004/000896 30.01.04 JP

Filing date 27 January 2005

Wipo publication date 11 August 2005

Acceptance publication date 5 July 2007

International Classifications

A61K 31/4184 (2006.01)

A61P 1/12 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2005/072730 Priority application(s): WO2005/072730

5 July 2007 Application Accepted

  Published as AU-B-2005209112

8 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209115-Anorectic compounds

2005209110-Anti-inflammatory analgesic for external use